Prevention of Venous Thromboembolism in High-Risk Patients by Prophylactic Administration of Oral Anticoagulants

  • Edwin W. Salzman

Abstract

In recent years the development of sensitive and specific noninvasive methods for diagnosis of venous thrombosis, with confirmation by phlebography, and improvements in the diagnostic methods available for detection of pulmonary embolism have made it possible to identify a number of major risk factors for venous thromboembolism. These features of a patient’s illness may be employed as criteria for selection of the patient as a candidate for prophylactic administration of antithrombotic agents. The more important risk factors that predispose to venous thromboembolism are shown in Table 1.

Keywords

Pulmonary Embolism Venous Thrombosis Venous Thromboembolism Oral Anticoagulant Prophylactic Administration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. Hirsh and E.W. Salzman, Prevention of venous thromboembolism, in: “Hemostasis and Thrombosis,” R.W. Colman, J. Hirsh, V.J. Marder, E.W. Salzman, eds., J.B. Lippincott Company, Philadelphia (1982).Google Scholar
  2. 2.
    C.M. Evarts and R.J. Alfidi, Thromboembolism after total hip reconstruction: Failure of low doses of heparin in prevention, J Am Med Assn. 225:515 (1973).CrossRefGoogle Scholar
  3. 3.
    W.G.J. Hampson, F.C. Harris, H.K. Lucas, P.H. Roberts, I.W. McCall, P.C. Jackson, N.L. Powell, and G.E. Staddon, Failure of low-dose heparin to prevent deep-vein thrombosis after hip replacement arthroplasty, Lancet 2:795 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    P.F. Leyvraz, J. Richard, F. Bachmann, G. Van Melle, J.M. Treyvaud, J.J. Livio, and G. Candardjis, Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement, N Engl J Med 309:954 (1983).PubMedCrossRefGoogle Scholar
  5. 5.
    V.V. Kakkar, P.J. Fok, W.J.G. Murray, T. Paes, D. Mereustein, R. Dodds, R. Farrell, R.Q. Crellin, E.M. Thomas, T.R. Morley, A.J. Price, Heparin and dihydroergotamine prophylaxis against thromboembolism after hip arthroplasty, J Bone Joint Surg. (Br) 67:538 (1985).Google Scholar
  6. 6.
    E.W. Salzman and G.C. Davies, Prophylaxis of venous thromboembolism, Ann Surg. 191:207 (1980).PubMedCrossRefGoogle Scholar
  7. 7.
    S. Sevitt and D. Innes, Prothrombin time and thrombotest in injured patients on prophylactic anticoagulant therapy, Lancet 1:124 (1964).PubMedCrossRefGoogle Scholar
  8. 8.
    R. Hull, J. Hirsh, R. Jay, D. Carter, C. England, M. Gent, A.G.G. Turpie, D. McLoughlin, P. Dodd, M. Thomas, G. Raskob, and P. Okelford, Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis, N Engl J Med. 207:1676 (1982).CrossRefGoogle Scholar
  9. 9.
    S. Sevitt and N.G. Gallagher, Prevention of venous thrombosis and pulmonary embolism in injured patients, Lancet 2:981 (1959).PubMedCrossRefGoogle Scholar
  10. 10.
    U.F. Gruber, Prevention of fatal pulmonary embolism in patients with fractures of the neck of the femur, Surg Gynecol Obstet. 161:37 (1985).PubMedGoogle Scholar
  11. 11.
    G.P. Clagett and E.W. Salzman, Prevention of venous thromboembolism, in: “Pulmonary Embolism,” A.A. Sasahara, E.H. Sonnenblick, M. Lesch, eds., Grune & Stratton, New York (1974, 1975).Google Scholar
  12. 12.
    G. Eskeland, K. Solheim, and F. Skjorten, Anticoagulant prophylaxis, thromboembolism, and mortality in elderly patients with hip fractures: Controlled clinical trial, Acta Chir Scand. 131:16 (1966).PubMedGoogle Scholar
  13. 13.
    S. Borgstrom, T. Greitz, W. Van der Linden, J. Molin, I. Rudics, Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur: A controlled clinical trial using venous phlebography, Acta Chir Scand. 129:500 (1965).Google Scholar
  14. 14.
    H.W. Hamilton, J.S. Crawford, J.H. Garginer, and A.M. Wiley, Venous thrombosis in patients with fracture of the upper end of the femur, J Bone Joint Surg. (Br) 52:268 (1970).Google Scholar
  15. 15.
    D.J. Pinto, Controlled trial of an anticoagulant (warfarin sodium) in the prevention of venous thrombosis following hip surgery, Brit J Surg. 57:349 (1970).PubMedCrossRefGoogle Scholar
  16. 16.
    M. Hume, X. Kuriakose, L. Zuch, and R.H. Turner, 125I fibrinogen and the prevention of venous thrombosis, Arch Surg. 107:803 (1973).PubMedCrossRefGoogle Scholar
  17. 17.
    T.J.M.V. van Vroonhoven, J. van Zijl, and H. Muller, Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep-venous thrombosis, Lancet 1:375 (1974).PubMedCrossRefGoogle Scholar
  18. 18.
    G.K. Morris and J.R.A. Mitchell, Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur, Lancet 2:869 (1976).PubMedCrossRefGoogle Scholar
  19. 19.
    D.A. Taberner, L. Poller, R.W. Burslem, and J.B. Jones, Oral anticoagulants controlled by the British comChapautive thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J. 1:272 (1978).PubMedCrossRefGoogle Scholar
  20. 20.
    C.W. Francis, V.J. Marder, C.M. Evarts, and S. Yaukoolbodi, Two-step warfarin therapy: Prevention of postoperative venous thrombosis without excessive bleeding, JAMA 249:374 (1983).PubMedCrossRefGoogle Scholar
  21. 21.
    W.H. Harris, J.K. Raines, C. Athanasoulis, A.C. Waltman, and E.W. Salzman, External pneumatic compression versus warfarin in reducing thrombosis in high-risk hip patients, in: “Venous Thrombosis: Prevention and Treatment,” J.L. Madden and M. Hume, eds., Appleton-Century, NY (1976).Google Scholar
  22. 22.
    M.B. Coventry, D.R. Nolan, and R.D. Beckenbaugh, “Delayed” prophylactic anticoagulation: A study of results and complications in 2,012 total hip arthroplasties, J Bone Joint Surg. 55A:1487 (1973).PubMedGoogle Scholar
  23. 23.
    W.J. Crawford, F. Hillman, and J. Charnley, A clinical trial of prophylactic anticoagulant therapy in elective hip surgery, Wrightington Internal Publications No. 14 (1968), cited in R. Johnson, J.R. Green, and J. Charnley, Pulmonary embolism and its prophylaxis following the Charnley total hip replacement, Clinical Orthopaedics and Related Research 127:123 (1977).Google Scholar
  24. 24.
    G. Paiement, S.J. Wessinger, A.C. Waltman, and W.H. Harris, Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement, Submitted for publication.Google Scholar
  25. 25.
    G. Paiement, S.J. Wessinger, and W.H. Harris, Cost effectiveness of prevention and early detection of venous thromboembolism in total hip replacement patients, Submitted for publication.Google Scholar
  26. 26.
    R.D. Guyer, R.E. Booth, and R.H. Rothman, The detection and prevention of pulmonary embolism in total hip replacement, J Bone Joint Surg. 64A: 1040 (1982).PubMedGoogle Scholar
  27. 27.
    E.W. Salzman, W.H. Harris, and R.W. DeSanctis, Anticoagulation for prevention of thromboembolism following fractures of the hip, N Engl J Med. 275:122 (1966).PubMedCrossRefGoogle Scholar
  28. 28.
    A.J. Zweifler, Relation of prothrombin concentration to bleeding during oral anticoagulant therapy: Its importance in detection of latent organic lesions, N Engl J Med. 267:283 (1962).CrossRefGoogle Scholar
  29. 29.
    O. Storm, Anticoagulant protection in surgery. Thromb Diath Haemorrh. 2:484 (1958).PubMedGoogle Scholar
  30. 30.
    H. Rustad and E. Myhre, Surgery during anticoagulant treatment: the risk of increased bleeding in patients on oral anticoagulant treatment, Acta Med Scand. 173:115 (1963).PubMedCrossRefGoogle Scholar
  31. 31.
    M.N. Levine, G. Raskob, and J. Hirsh, Hemorrhagic complications of long-term anticoagulant therapy, Chest 89:16S (1986).Google Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Edwin W. Salzman
    • 1
  1. 1.Harvard Medical SchoolBeth Israel HospitalBostonUSA

Personalised recommendations